deepeye Medical

Deepeye is a promising startup harnessing the power of deep learning technology to revolutionize eye care. Its slogan "Deepeye uses AI to diagnose and treat common eye diseases, preventing over 90% of blindness" epitomizes its mission to combat prevalent eye conditions. Founded in 2021, the company operates in the Health Care sector, with a focal point on Age-related Macular Degeneration (AMD) which affects over 12% of the European population. Through its Seed Round investment of €2.50M on 07 November 2023, it attracted funding from noteworthy investors including Bayern Kapital, Springboard Health Angels, Arve Capital, and YZR Capital. This injection of capital will likely propel Deepeye's cutting-edge image recognition software forward, enabling advanced diagnosis and personalized treatment plans that have the potential to prevent an astounding 90% of all blindness cases. This innovative approach positions Deepeye as a formidable player in the intersection of AI and eye care, with the potential to significantly impact global health outcomes.